Association of CDK15 and L1CAM Expression in Cervical Cancer Tissues with Clinicopathological Characteristics and Recurrence/Metastasis After Radical Hysterectomy.

IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Jingjing Li, Yuanyuan Su, Limin Chen, Yan An, Lin Shen
{"title":"Association of CDK15 and L1CAM Expression in Cervical Cancer Tissues with Clinicopathological Characteristics and Recurrence/Metastasis After Radical Hysterectomy.","authors":"Jingjing Li, Yuanyuan Su, Limin Chen, Yan An, Lin Shen","doi":"10.12669/pjms.42.3.13277","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the association of CDK15(cyclin-dependent kinase 15) and L1CAM L1 (cell adhesion molecule) expression with clinicopathological characteristics and recurrence and/or metastasis after radical hysterectomy of cervical cancer.</p><p><strong>Methodology: </strong>Retrospective analysis was performed on the clinical data of 80 patients with pathologically confirmed cervical cancer who underwent radical hysterectomy at Affiliated Hospital of Hebei University between January 2023 to January 2025. Differences in CDK15 and L1CAM L1 expression in cervical cancer tissues were compared across subgroups stratified by different clinicopathological characteristics, including age and International Federation of Gynecology and Obstetrics(FIGO) stage. Recurrence and metastasis in cervical cancer patients were documented within 12 months post-radical hysterectomy. The Kaplan-Meier method was employed to analyze the association of CDK15/L1CAM expression with recurrence-free survival(RFS).</p><p><strong>Results: </strong>The positive expression rates of CDK15 and L1CAM in cervical cancer tissues were 51.25% and 47.50%, respectively-both significantly higher than the corresponding rates of 22.50% and 18.75% in adjacent non-cancerous tissues(P<0.05). In cervical cancer tissues, the expression of CDK15 exhibited statistically significant differences across subgroups stratified by FIGO stage, histological differentiation, lymph node metastasis, and lymphovascular invasion(P<0.05); whereas the expression of L1CAM demonstrated statistically significant differences across subgroups stratified by FIGO stage, maximum tumor diameter, and lymph node metastasis(P<0.05). Kaplan-Meier analysis revealed that the 12 months RFS rate after radical hysterectomy was approximately 68.29% in cervical cancer patients with positive CDK15 expression, which was lower than the 89.74% in patients with negative CDK15 expression(Log-rank P=0.019).</p><p><strong>Conclusion: </strong>CDK15 and L1CAM are highly expressed in cervical cancer tissues. Consequently, CDK15 and L1CAM hold promise as novel prognostic biomarkers and potential therapeutic targets for cervical cancer.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"42 3","pages":"621-628"},"PeriodicalIF":1.2000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13080089/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12669/pjms.42.3.13277","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the association of CDK15(cyclin-dependent kinase 15) and L1CAM L1 (cell adhesion molecule) expression with clinicopathological characteristics and recurrence and/or metastasis after radical hysterectomy of cervical cancer.

Methodology: Retrospective analysis was performed on the clinical data of 80 patients with pathologically confirmed cervical cancer who underwent radical hysterectomy at Affiliated Hospital of Hebei University between January 2023 to January 2025. Differences in CDK15 and L1CAM L1 expression in cervical cancer tissues were compared across subgroups stratified by different clinicopathological characteristics, including age and International Federation of Gynecology and Obstetrics(FIGO) stage. Recurrence and metastasis in cervical cancer patients were documented within 12 months post-radical hysterectomy. The Kaplan-Meier method was employed to analyze the association of CDK15/L1CAM expression with recurrence-free survival(RFS).

Results: The positive expression rates of CDK15 and L1CAM in cervical cancer tissues were 51.25% and 47.50%, respectively-both significantly higher than the corresponding rates of 22.50% and 18.75% in adjacent non-cancerous tissues(P<0.05). In cervical cancer tissues, the expression of CDK15 exhibited statistically significant differences across subgroups stratified by FIGO stage, histological differentiation, lymph node metastasis, and lymphovascular invasion(P<0.05); whereas the expression of L1CAM demonstrated statistically significant differences across subgroups stratified by FIGO stage, maximum tumor diameter, and lymph node metastasis(P<0.05). Kaplan-Meier analysis revealed that the 12 months RFS rate after radical hysterectomy was approximately 68.29% in cervical cancer patients with positive CDK15 expression, which was lower than the 89.74% in patients with negative CDK15 expression(Log-rank P=0.019).

Conclusion: CDK15 and L1CAM are highly expressed in cervical cancer tissues. Consequently, CDK15 and L1CAM hold promise as novel prognostic biomarkers and potential therapeutic targets for cervical cancer.

CDK15和L1CAM在宫颈癌组织中的表达与根治性子宫切除术后临床病理特征和复发/转移的关系
目的:探讨细胞周期蛋白依赖性激酶15(cyclin-dependent kinase 15)和细胞粘附分子L1 (L1CAM L1)表达与宫颈癌根治性子宫切除术后临床病理特征及复发和/或转移的关系。方法:回顾性分析2023年1月至2025年1月河北大学附属医院经病理证实行根治性子宫切除术的80例宫颈癌患者的临床资料。比较CDK15和L1CAM L1在不同临床病理特征(包括年龄和国际妇产科学联合会(FIGO)分期)分层子宫颈癌组织中的表达差异。宫颈癌患者在根治性子宫切除术后12个月内发生复发和转移。采用Kaplan-Meier法分析CDK15/L1CAM表达与无复发生存率(RFS)的关系。结果:CDK15和L1CAM在宫颈癌组织中的阳性表达率分别为51.25%和47.50%,均显著高于癌旁非癌组织的阳性表达率22.50%和18.75% (p结论:CDK15和L1CAM在宫颈癌组织中高表达。因此,CDK15和L1CAM有望成为宫颈癌新的预后生物标志物和潜在的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pakistan Journal of Medical Sciences
Pakistan Journal of Medical Sciences 医学-医学:内科
CiteScore
4.10
自引率
9.10%
发文量
363
审稿时长
3-6 weeks
期刊介绍: It is a peer reviewed medical journal published regularly since 1984. It was previously known as quarterly "SPECIALIST" till December 31st 1999. It publishes original research articles, review articles, current practices, short communications & case reports. It attracts manuscripts not only from within Pakistan but also from over fifty countries from abroad. Copies of PJMS are sent to all the import medical libraries all over Pakistan and overseas particularly in South East Asia and Asia Pacific besides WHO EMRO Region countries. Eminent members of the medical profession at home and abroad regularly contribute their write-ups, manuscripts in our publications. We pursue an independent editorial policy, which allows an opportunity to the healthcare professionals to express their views without any fear or favour. That is why many opinion makers among the medical and pharmaceutical profession use this publication to communicate their viewpoint.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书